ASML's CEO, Christophe Fouquet, stated that the company remains unaffected by the issues between The Netherlands and China over Nexperia. Though Nexperia faces supply challenges due to a halt in its Chinese plant, a Dutch delegation plans to engage China for further discussions next week.
ASML CEO: Dutch Nexperia Tensions Won't Hinder Us